Advances in monoclonal antibody therapy of cancer

A. F. LoBuglio, M. N. Saleh

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


Tumor-associated antigens can be seen as unique targets for the delivery of anti-cancer therapy. Monoclonal antibodies directed at such antigens are increasingly being seen as important biologic reagents that will complement the group of existing cytotoxic drugs. This report briefly overviews recent advances in the field of monoclonal antibody therapy of cancer and provides insight regarding the promises and limitations of this novel therapeutic approach.

Original languageEnglish
Pages (from-to)214-224
Number of pages11
JournalAmerican Journal of the Medical Sciences
Issue number3
Publication statusPublished - 1992
Externally publishedYes


  • Cancer
  • Immunotherapy
  • Monoclonal antibody


Dive into the research topics of 'Advances in monoclonal antibody therapy of cancer'. Together they form a unique fingerprint.

Cite this